Generic drugs the pay-for-delay problem /
Spremljeno u:
Autor kompanije: | ebrary, Inc |
---|---|
Daljnji autori: | Curtin, Christina M. |
Format: | Elektronički e-knjiga |
Jezik: | engleski |
Izdano: |
New York :
Nova Biomedical/Nova Science Publishers,
c2011.
|
Serija: | Public health in the 21st century series.
|
Teme: | |
Online pristup: | An electronic book accessible through the World Wide Web; click to view |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Slični predmeti
Pharmaceutical pricing policies in a global market
Izdano: (2008)
Izdano: (2008)
Les prix des medicaments sur un marche global politiques et enjeux.
Izdano: (2008)
Izdano: (2008)
Generic drugs needs and issues /
Izdano: (2009)
Izdano: (2009)
The $800 million pill the truth behind the cost of new drugs /
od: Goozner, Merrill, 1950-
Izdano: (2004)
od: Goozner, Merrill, 1950-
Izdano: (2004)
The competitive status of the U.S. pharmaceutical industry the influences of technology in determining international industrial competitive advantage /
Izdano: (1983)
Izdano: (1983)
Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
od: Osmane, Malik
Izdano: (2014)
od: Osmane, Malik
Izdano: (2014)
Driving down the cost of drugs : battling big pharma in the statehouse /
od: Castellblanch, Ram�on, 1948-
Izdano: (2012)
od: Castellblanch, Ram�on, 1948-
Izdano: (2012)
Pharmaceutical economics and policy
od: Schweitzer, Stuart O.
Izdano: (2007)
od: Schweitzer, Stuart O.
Izdano: (2007)
Marketing Strategies Adopted by Generic and Original Drugs Manufacturing Companies in An Effort to Attain Strategic Competitiveness: A Study of Mombasa
od: Mueni, Matingi Ireen
Izdano: (2024)
od: Mueni, Matingi Ireen
Izdano: (2024)
The WetFeet insider guide to the top 20 biotechnology and pharmaceutical firms /
Izdano: (2003)
Izdano: (2003)
Profits before people? ethical standards and the marketing of prescription drugs /
od: Weber, Leonard J., 1942-
Izdano: (2006)
od: Weber, Leonard J., 1942-
Izdano: (2006)
CAPA for the FDA-regulated industry /
od: Rodríguez Pérez, José, 1961-
Izdano: (2010)
od: Rodríguez Pérez, José, 1961-
Izdano: (2010)
The risks of prescription drugs
Izdano: (2010)
Izdano: (2010)
ADME-enabling technologies for drug design and development
Izdano: (2012)
Izdano: (2012)
Drug discovery and design medical aspects /
Izdano: (2002)
Izdano: (2002)
Drugs : from discovery to approval /
od: Ng, Rick
Izdano: (2015)
od: Ng, Rick
Izdano: (2015)
Drug discovery practices, processes, and perspectives /
Izdano: (2013)
Izdano: (2013)
The art of drug synthesis
Izdano: (2007)
Izdano: (2007)
Modern drug synthesis
Izdano: (2010)
Izdano: (2010)
Successful drug discovery.
Izdano: (2015)
Izdano: (2015)
Chemical drug design /
Izdano: (2016)
Izdano: (2016)
Towards drugs of the future key issues in lead finding and lead optimization /
Izdano: (2008)
Izdano: (2008)
Drug repositioning bringing new life to shelved assets and existing drugs /
Izdano: (2012)
Izdano: (2012)
Frontiers in drug design and discovery.
Izdano: (2010)
Izdano: (2010)
Drug-like properties concepts, structure design and methods : from ADME to toxicity optimization /
od: Kerns, Edward Harvel
Izdano: (2008)
od: Kerns, Edward Harvel
Izdano: (2008)
Drug delivery strategies for poorly water-soluble drugs
Izdano: (2012)
Izdano: (2012)
Pharmaceutical blending and mixing /
Izdano: (2015)
Izdano: (2015)
Pharmaceutical industry innovation and developments /
Izdano: (2011)
Izdano: (2011)
Drug delivery principles and applications /
od: Wang, Binghe
Izdano: (2005)
od: Wang, Binghe
Izdano: (2005)
Drug delivery : principles and applications /
Izdano: (2016)
Izdano: (2016)
Case studies in modern drug discovery and development
Izdano: (2012)
Izdano: (2012)
The agile approach to adaptive research optimizing efficiency in clinical development /
od: Rosenberg, Michael J.
Izdano: (2010)
od: Rosenberg, Michael J.
Izdano: (2010)
Therapeutic targets modulation, inhibition, and activation /
Izdano: (2012)
Izdano: (2012)
Manufacturing of pharmaceutical proteins : from technology to economy /
od: Behme, Stefan
Izdano: (2015)
od: Behme, Stefan
Izdano: (2015)
Advanced drug delivery /
Izdano: (2013)
Izdano: (2013)
How to develop and implement a national drug policy
Izdano: (2001)
Izdano: (2001)
Predictive approaches in drug discovery and development biomarkers and in vitro/in vivo correlations /
Izdano: (2012)
Izdano: (2012)
Effective drug regulation a multicountry study /
od: Ratanawijitrasin, Sauwakon
Izdano: (2002)
od: Ratanawijitrasin, Sauwakon
Izdano: (2002)
The future of drug safety promoting and protecting the health of the public /
Izdano: (2007)
Izdano: (2007)
Outsourcing clinical development strategies for working with CROs and other partners /
Izdano: (2006)
Izdano: (2006)
Slični predmeti
-
Pharmaceutical pricing policies in a global market
Izdano: (2008) -
Les prix des medicaments sur un marche global politiques et enjeux.
Izdano: (2008) -
Generic drugs needs and issues /
Izdano: (2009) -
The $800 million pill the truth behind the cost of new drugs /
od: Goozner, Merrill, 1950-
Izdano: (2004) -
The competitive status of the U.S. pharmaceutical industry the influences of technology in determining international industrial competitive advantage /
Izdano: (1983)